Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Pulmonary Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02048644
What this trial is testing

Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hull University Teaching Hospitals NHS Trust 20
Post-approval studies (Phase 4)Study completedNCT02598193
What this trial is testing

Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 89
Testing effectiveness (Phase 2)Active Not RecruitingNCT05389215
What this trial is testing

Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical Co. LTD. 102
Not applicableEnrolling By InvitationNCT06885515
What this trial is testing

Telomeres Length in Israeli Fibrotic ILD Patients

Who this might be right for
Pulmonary Fibrosis
Barzilai Medical Center 100
Not applicableUnknownNCT05719038
What this trial is testing

Diagnostic and Prognostic Model of Pulmonary Fibrosis After COVID-19 Pneumonia and Mechanism Study

Who this might be right for
Pulmonary FibrosisCOVID-19
Kunming Medical University 200
Not applicableApproved For MarketingNCT02141087
What this trial is testing

Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone

Who this might be right for
Idiopathic Pulmonary Fibrosis
Genentech, Inc.
Not applicableStudy completedNCT00815711
What this trial is testing

Idiopathic Pulmonary Fibrosis Registry for Future Studies

Who this might be right for
Lung Disease, InterstitialIdiopathic Pulmonary Fibrosis
Ohio State University 13
Testing effectiveness (Phase 2)Study completedNCT04527354
What this trial is testing

Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia

Who this might be right for
SARS-CoV-2 InfectionFibrosis Lung
PHARMENTERPRISES LLC 60
Testing effectiveness (Phase 2)Study completedNCT00063869
What this trial is testing

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Wyeth is now a wholly owned subsidiary of Pfizer 88
Not applicableUnknownNCT06445686
What this trial is testing

Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation.

Who this might be right for
Idiopathic Pulmonary Fibrosis
Biosency 30
Large-scale testing (Phase 3)Study completedNCT01335477
What this trial is testing

Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 551
Very early researchActive Not RecruitingNCT05365802
What this trial is testing

FAPI PET for Lung Fibrosis

Who this might be right for
Interstitial Lung DiseaseIdiopathic Interstitial PneumoniasDrug-Induced Pneumonitis+4 more
University of California, Los Angeles 30
Post-approval studies (Phase 4)UnknownNCT03260556
What this trial is testing

Pirfenidone for Progressive Fibrotic Sarcoidosis

Who this might be right for
Sarcoidosis, Pulmonary
University of Cincinnati 60
Testing effectiveness (Phase 2)Looking for participantsNCT07572383
What this trial is testing

Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

Who this might be right for
Interstitial Lung DiseasePulmonary Fibrosis
Peter Caravan 15
Not applicableNot Yet RecruitingNCT07627594
What this trial is testing

Safety of Bronchoscopy in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease (ILD)BronchoscopyBronchoalveolar Lavage (BAL)+5 more
University of Milan 427
Testing effectiveness (Phase 2)Study completedNCT04308681
What this trial is testing

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 403
Early research (Phase 1)Study completedNCT06589219
What this trial is testing

Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibroses, Idiopathic
Calibr, a division of Scripps Research 89
Testing effectiveness (Phase 2)Study completedNCT00455767
What this trial is testing

Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients

Who this might be right for
FibrosisLung DiseaseRespiratory Disorders+4 more
Debiopharm International SA 84
Post-approval studies (Phase 4)Study completedNCT03939520
What this trial is testing

Management of Progressive Disease in Idiopathic Pulmonary Fibrosis

Who this might be right for
Progressive Idiopathic Pulmonary Fibrosis
Hospices Civils de Lyon 279
Large-scale testing (Phase 3)Looking for participantsNCT05075161
What this trial is testing

Pirfenidone to Prevent Fibrosis in Ards.

Who this might be right for
Acute Respiratory Distress Syndrome (ARDS)
Università Vita-Salute San Raffaele 130
Next Page